Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Other Operating Expenses (2020 - 2025)

Treace Medical Concepts' Other Operating Expenses history spans 6 years, with the latest figure at $88000.0 for Q4 2025.

  • For Q4 2025, Other Operating Expenses fell 25.42% year-over-year to $88000.0; the TTM value through Dec 2025 reached $432000.0, up 33.33%, while the annual FY2025 figure was $432000.0, 33.33% up from the prior year.
  • Other Operating Expenses reached $88000.0 in Q4 2025 per TMCI's latest filing, down from $92000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $23.3 million in Q4 2021 to a low of -$357000.0 in Q4 2022.
  • Average Other Operating Expenses over 5 years is $3.3 million, with a median of $95500.0 recorded in 2023.
  • Peak YoY movement for Other Operating Expenses: plummeted 101.53% in 2022, then surged 6300.0% in 2023.
  • A 5-year view of Other Operating Expenses shows it stood at $23.3 million in 2021, then tumbled by 101.53% to -$357000.0 in 2022, then soared by 126.89% to $96000.0 in 2023, then grew by 22.92% to $118000.0 in 2024, then dropped by 25.42% to $88000.0 in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Other Operating Expenses are $88000.0 (Q4 2025), $92000.0 (Q3 2025), and $122000.0 (Q2 2025).